RxDoctor Payments DataLook up a doctor →

Troy Henderson

Primary Care · Fultondale, ALNPI 1609324003

Payments from drug & device makers

$18,033in general payments, 2019–2025

Across 1,030 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • GSK$2K
  • Novo Nordisk$2K
  • Medtronic$1K
  • Boehringer Ingelheim$1K
  • Bayer$1K
  • plus $9K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie161$1,980
GSK101$1,943
Novo Nordisk124$1,845
Medtronic19$1,279
Boehringer Ingelheim70$1,197
Bayer66$1,189
Lilly USA, LLC58$1,025
AstraZeneca58$1,019
Pfizer52$856
Amgen(2 entities)44$815
Takeda Pharmaceuticals U.S.A., Inc.26$566
Ironwood Pharmaceuticals, Inc16$308
Axsome Therapeutics, Inc.10$238
Amarin Pharma, Inc.15$222
Kowa Pharmaceuticals America, Inc.20$213
Biohaven Pharmaceutical Holding Company Ltd.14$181
Antares Pharma, Inc.8$176
Johnson & Johnson10$165
Paratek Pharmaceuticals, Inc.10$162
Corcept Therapeutics6$157
Ardelyx, Inc.7$142
Sunovion Pharmaceuticals Inc.15$139
Astellas Pharma US Inc8$139
Dexcom, Inc.6$128
Biohaven Pharmaceuticals, Inc.10$128
Otsuka America Pharmaceutical, Inc.6$116
Biogen6$113
Sanofi-aventis U.S. LLC5$107
Radius Health, Inc.5$104
Alkermes, Inc.5$98
Corium, LLC4$95
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$92
Lundbeck LLC3$85
Novartis4$85
Abbott4$81
E.r. Squibb & Sons, L.L.C.4$73
Esperion Therapeutics, Inc.4$67
Almatica Pharma LLC3$66
Jazz Pharmaceuticals Inc.3$63
Sumitomo Pharma America, Inc.3$60
Merck3$57
Exact Sciences3$46
Xeris Pharmaceuticals, Inc.2$41
Eisai Inc.3$41
Vanda Pharmaceuticals Inc.1$39
Teva Pharmaceuticals USA, Inc.3$37
Boston Scientific2$36
IBSA Pharma Inc.2$35
Phathom Pharmaceuticals, Inc.2$32
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$31
Idorsia Pharmaceuticals US Inc2$29
Genentech USA, Inc.1$21
Tonix Medicines, Inc.1$17
Alnylam Pharmaceuticals Inc.1$15
Scilex Pharmaceuticals Inc.1$15
Avanir Pharmaceuticals, Inc.1$13
Nestle Healthcare Nutrition Inc.1$12

How this compares

$18,033 in reported general payments places this provider in the 95th percentile of 159 primary care providers in Alabama.

See all primary care providers in Alabama →

Medicare billing

Part B allowed, 2024
$45,515
Medicare patients
204
Services billed
2,238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other primary care in Fultondale

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →